IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation

Frank Mercurio(SignalRx Pharmaceuticals (United States)), Hengyi Zhu(SignalRx Pharmaceuticals (United States)), Brion W. Murray(SignalRx Pharmaceuticals (United States)), Andrej Shevchenko(SignalRx Pharmaceuticals (United States)), Brydon L. Bennett(SignalRx Pharmaceuticals (United States)), Jian Wu Li(SignalRx Pharmaceuticals (United States)), David B. Young(SignalRx Pharmaceuticals (United States)), Miguel Barbosa(SignalRx Pharmaceuticals (United States)), Matthias Mann(SignalRx Pharmaceuticals (United States)), Anthony M. Manning(SignalRx Pharmaceuticals (United States)), Anjana Rao(SignalRx Pharmaceuticals (United States))
Science
October 31, 1997
Cited by 2,042

Abstract

Activation of the transcription factor nuclear factor kappa B (NF-kappaB) is controlled by sequential phosphorylation, ubiquitination, and degradation of its inhibitory subunit IkappaB. A large multiprotein complex, the IkappaB kinase (IKK) signalsome, was purified from HeLa cells and found to contain a cytokine-inducible IkappaB kinase activity that phosphorylates IkappaB-alpha and IkappaB-beta. Two components of the IKK signalsome, IKK-1 and IKK-2, were identified as closely related protein serine kinases containing leucine zipper and helix-loop-helix protein interaction motifs. Mutant versions of IKK-2 had pronounced effects on RelA nuclear translocation and NF-kappaB-dependent reporter activity, consistent with a critical role for the IKK kinases in the NF-kappaB signaling pathway.


Related Papers